← Back to Search

Virtual Reality Technology

VR Gaming Therapy for Stroke Rehabilitation

N/A
Recruiting
Led By Seema S Aggarwal, PhD, APRN, AGNP-C
Research Sponsored by The University of Texas Health Science Center, Houston
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, after each session (3 times a week for 4 weeks about 12 total sessions)
Awards & highlights

Study Summary

This trial tests if a virtual reality game can help stroke survivors with arm and cognitive impairments, and the impact it has on caregivers.

Who is the study for?
This trial is for chronic stroke survivors who had a stroke between 6 months to 2 years ago, can communicate in English, and are able to consent. They should have mild-moderate cognitive and arm impairments but cannot join if they have severe cognitive issues, certain neurological deficits like aphasia or hemiopsia, motion sickness/vertigo/dizziness/seizures, claustrophobia, blindness/deafness or can't hold the controller.Check my eligibility
What is being tested?
The study tests how feasible and acceptable it is for stroke survivors with arm and cognitive impairments to use Oculus VR technology for rehabilitation. It measures changes in their abilities using standard tests and includes interviews with caregivers about their involvement in the rehab process.See study design
What are the potential side effects?
Potential side effects of using Oculus VR may include discomfort such as dizziness or nausea (especially if prone to motion sickness), eye strain from prolonged screen exposure, headaches due to virtual reality immersion or fatigue from physical activity during gaming.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, after each session (3 times a week for 4 weeks about 12 total sessions)
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, after each session (3 times a week for 4 weeks about 12 total sessions) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Acceptability (ease of use) as assessed by the score on the Simulator Sickness Questionnaire (SSQ) questionnaire
Change in arm impairment as assessed by Fugl Meyer - Upper Extremity assessment
Change in burden of caregivers in supporting the stroke survivor as assessed by the Burden Scale for Family Caregivers - short version
+6 more
Secondary outcome measures
Change in Impact of the rehabilitation on the caregiver as assessed by the qualitative interview
Change in Impact of the rehabilitation on the participant as assessed by the qualitative interview
Number of subjects who have received occupational therapy
+2 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Oculus VRExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

IoT and Aging in Place Joint Seed GrantUNKNOWN
The University of Texas Health Science Center, HoustonLead Sponsor
904 Previous Clinical Trials
320,920 Total Patients Enrolled
42 Trials studying Stroke
7,367 Patients Enrolled for Stroke
Seema S Aggarwal, PhD, APRN, AGNP-CPrincipal InvestigatorThe University of Texas Health Science Center, Houston

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are individuals still invited to participate in this research endeavor?

"According to the clinicaltrials.gov database, this research project is not currently in search of new participants; it was initially posted on September 1st 2023 and last updated December 20th 2022. Despite that, there are 993 other trials with active recruitment at present."

Answered by AI

Who else is applying?

What state do they live in?
Texas
What portion of applicants met pre-screening criteria?
Met criteria
~5 spots leftby Jun 2024